Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Allison R Coker"'
Autor:
Bessel A van der Kolk, Julie B Wang, Rachel Yehuda, Leah Bedrosian, Allison R Coker, Charlotte Harrison, Michael Mithoefer, Berra Yazar-Klosinki, Amy Emerson, Rick Doblin
Publikováno v:
PLoS ONE, Vol 19, Iss 1, p e0295926 (2024)
IntroductionThere is a resurgence of interest in the therapeutic potential of psychedelic substances such as 3,4-methylenedioxymethamphetamine (MDMA). Primary findings from our randomized, double-blind, placebo-controlled, multi-site Phase 3 clinical
Externí odkaz:
https://doaj.org/article/af757185a4bb47e1b00ece3c0c4b3854
Publikováno v:
PLoS ONE, Vol 5, Iss 12, p e15222 (2010)
Brain regions typically contain intermixed subpopulations of neurons with different connectivity and neurotransmitters. This complicates identification of neuronal phenotypes in electrophysiological experiments without using direct detection of uniqu
Externí odkaz:
https://doaj.org/article/9b8f11c9427f48aaaee2ed718ce78946
Autor:
S. Parker Singleton, Julie B. Wang, Michael Mithoefer, Colleen Hanlon, Mark S. George, Annie Mithoefer, Oliver Mithoefer, Allison R. Coker, Berra Yazar-Klosinski, Amy Emerson, Rick Doblin, Amy Kuceyeski
Introduction3,4-methylenedioxymethamphetamine-assisted therapy (MDMA-AT) for post-traumatic stress disorder (PTSD) has demonstrated promise in multiple clinical trials. MDMA is hypothesized to facilitate the therapeutic process, in part, by decreasin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57fbe2f7ceb173f55355467b2b8ac03b
https://doi.org/10.1101/2022.05.25.22275473
https://doi.org/10.1101/2022.05.25.22275473
Autor:
Jack E. Henningfield, Marion A. Coe, Roland R. Griffiths, Sean J. Belouin, Ann Berger, Allison R. Coker, Sandra D. Comer, David J. Heal, Peter S. Hendricks, Charles D. Nichols, Frank Sapienza, Frank J. Vocci, Farah Z. Zia
Publikováno v:
Neuropharmacology. 218
New medicines containing classic hallucinogenic and entactogenic psychedelic substance are under development for various psychiatric and neurological disorders. Many of these, including psilocybin, lysergic acid diethylamide (LSD), and 3,4-methylened
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8ac062d4ee3223273134a1958028fec
https://pubmed.ncbi.nlm.nih.gov/35987353
https://pubmed.ncbi.nlm.nih.gov/35987353
Autor:
Christopher R. Nicholas, Keren Tzarfaty, Ann T Mithoefer, Ray Worthy, Amy Emerson, Simon Amar, Charlotte Harrison, Sarah Kleiman, Ingmar Gorman, Kelly Parker-Guilbert, Michael P. Bogenschutz, Sukhpreet S. Klaire, Alberdina de Boer, Emma Hapke, Bessel A. van der Kolk, Berra Yazar-Klosinski, Michael C. Mithoefer, Allison R. Coker, Rick Doblin, Cole Marta, Wael Garas, Jennifer M. Mitchell, Scott Hamilton, Sylvestre Quevedo, Rebecca Matthews, Yair Wallach, G. M. Wells, Marcela Ot’alora G., Randall Brown, Bruce Poulter, Joshua D. Woolley, Yevgeniy Gelfand, Casey Paleos, Shannon Carlin, Scott Shannon, Alia Lilienstein, Revital Amiaz, Julie B. Wang
Publikováno v:
Nature medicine, vol 27, iss 6
Post-traumatic stress disorder (PTSD) presents a major public health problem for which currently available treatments are modestly effective. We report the findings of a randomized, double-blind, placebo-controlled, multi-site phase 3 clinical trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b51eadf9452e201a5e59273668aa143
https://escholarship.org/uc/item/9pm86760
https://escholarship.org/uc/item/9pm86760
Publikováno v:
Nature Medicine. 27:1691-1692
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5448de54747bf43cf51d68deb99767a0
https://doi.org/10.1038/s41591-021-01526-z
https://doi.org/10.1038/s41591-021-01526-z
Autor:
Taylor Vega, Catriona S. Miller, Allison R. Coker, Jennifer M. Mitchell, Dawn Weinstein, Andrew S. Kayser
Publikováno v:
Psychopharmacology (Berl)
Psychopharmacology, vol 237, iss 10
Psychopharmacology, vol 237, iss 10
RationaleIndividuals suffering from alcohol use disorder (AUD) demonstrate difficulty with decision-making and impulsivity that may be associated with impaired frontal cortical function. Therapeutics that enhance frontal dopamine tone could decrease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::942c6b9c9c627d6ce549c33e2a735f60
https://pubmed.ncbi.nlm.nih.gov/32617646
https://pubmed.ncbi.nlm.nih.gov/32617646
Autor:
Rebecca Matthews, Ilsa Jerome, Rick Doblin, Jessica Lin, Allison R. Coker, Julie B. Wang, Alia Lilienstein, Amy Emerson, G Marcela Ot’alora, Elizabeth Heimler, Michael C. Mithoefer, Leah Bedrosian, Berra Yazar-Klosinski, Charlotte Harrison, Shannon Carlin, Annie Mithoefer, Bruce Poulter, Allison A. Feduccia
Publikováno v:
Journal of Humanistic Psychology. :002216782110236
Background: Posttraumatic stress disorder (PTSD) is a debilitating mental health condition associated with serious adverse health outcomes and functional impairment. Previous MDMA–assisted therapy (MDMA-AT) studies have shown promising results in s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ec6c2bfca6a67a22c651454bd5d0504
https://doi.org/10.1177/00221678211023663
https://doi.org/10.1177/00221678211023663
Autor:
Allison R. Coker, Daicia C. Allen, Elyssa B. Margolis, Jennifer M. Mitchell, Howard L. Fields
Publikováno v:
Alcoholism: Clinical and Experimental Research. 38:195-203
Background While there is a growing body of evidence that the delta opioid receptor (DOR) modulates ethanol (EtOH) consumption, development of DOR-based medications is limited in part because there are 2 pharmacologically distinct DOR subtypes (DOR-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::712c3997fc60e40f7bbe5961fb99403b
https://doi.org/10.1111/acer.12246
https://doi.org/10.1111/acer.12246
Publikováno v:
Behavioral neuroscience, vol 126, iss 4
The delta opioid receptor (DOR) agonist DPDPE decreases ethanol (EtOH) consumption when injected into the ventral tegmental area (VTA). We previously showed that DPDPE inhibition of GABAA receptor-mediated inhibitory postsynaptic currents (GABAAR IPS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bfcc3d092bbe00d7588f7d3377e1242
https://europepmc.org/articles/PMC3669671/
https://europepmc.org/articles/PMC3669671/